TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 143.00
-1.00 (-0.69%)
At close: Mar 6, 2026
TMS Co., Ltd. Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
6.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Feb 28, 2025 | - | - | - |
| Feb 29, 2024 | - | - | - |
| Feb 28, 2023 | - | - | - |
| Feb 28, 2022 | 1.95B | - | - |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.32B |
| Kohjin Bio | 5.07B |
| Soiken Holdings | 4.58B |
| CellSource | 3.71B |
| OncoTherapy Science | 784.00M |
| PRISM BioLab Co.,LTD | 684.61M |
| Chiome Bioscience | 593.29M |
| Carna Biosciences | 579.06M |